Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder

Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder

Publication date: May 14, 2019

This is a non-inferiority randomized clinical trial that will compare slow release oral morphine vs methadone as a second line oral treatment for opioid use disorder.

Concepts Keywords
Abstinence Heroin
Adverse Drug Reaction Buprenorphine
Agonist Morphine
Allergy Methadone
Amenorrhea Ethers
Benzodiazepines Morphinans
Breastfeeding Drug rehabilitation
British Columbia Opioids
Buprenorphine RTT
Contraception Euphoriants
DSM Contraception
Hypersensitivity Reaction Hysterectomy
Hysterectomy Opioid disorder
Informed Consent Allergy
Interact
Investigational Drug
Methadone
Morphine
Oophorectomy
Opioid
Patient Reported Outcomes
Physical Examination
Physician
Postmenopausal
Pregnancy Test
Psychiatric Condition
Randomization
Randomized Clinical Trial
Randomized Controlled Trial
Slow Release
Surgical Sterilization
Tolerability
Tubal Ligation
Vital Signs

Semantics

Type Source Name
gene UNIPROT NR4A2
gene UNIPROT ALG3
disease DOID hypersensitivity
drug DRUGBANK Buprenorphine
disease MESH substance use disorder
gene UNIPROT RNMT
gene UNIPROT MET
gene UNIPROT SLTM
drug DRUGBANK Methionine
disease DOID amenorrhea
disease MESH amenorrhea
disease MESH Mental Disorders
gene UNIPROT OAT
pathway BSID Release
drug DRUGBANK Morphine
drug DRUGBANK Methadone
disease MESH hypersensitivity
disease MESH adverse drug reaction

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *